APPOINTMENT OF SOLE BROKER-SAREUM HOLDINGS PLC

APPOINTMENT OF SOLE BROKER-SAREUM HOLDINGS PLC

Appointment of Sole Broker

 

Cambridge, UK, 30 May 2024 - Sareum Holdings plc (AIM: SAR), a clinical-stage biotechnology company developing next-generation kinase inhibitors for autoimmune disease and cancer, announces that Hybridan LLP is now acting as the Company's sole broker with immediate effect.

No Comments

Post a Comment